Adam Walters - Publications

Affiliations: 
2017- Institute of Pharmaceutical Science King's College London, London, UK 

18 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Qin Y, Rouatbi N, Wang JT, Baker R, Spicer J, Walters AA, Al-Jamal KT. Plasmid DNA Ionisable lipid nanoparticles as non-inert carriers and potent immune activators for cancer immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 38493950 DOI: 10.1016/j.jconrel.2024.03.018  0.783
2023 Qin Y, Walters AA, Rouatbi N, Wang JT, Abdel-Bar HM, Al-Jamal KT. Evaluation of a DoE based approach for comprehensive modelling of the effect of lipid nanoparticle composition on nucleic acid delivery. Biomaterials. 299: 122158. PMID 37243988 DOI: 10.1016/j.biomaterials.2023.122158  0.754
2022 Qin Y, Walters AA, Al-Jamal KT. Plasmid DNA cationic non-viral vector complexes induce cytotoxicity-associated PD-L1 expression up-regulation in cancer cells in vitro. International Journal of Pharmaceutics. 122481. PMID 36513254 DOI: 10.1016/j.ijpharm.2022.122481  0.656
2022 Walters AA, Ali A, Wang JT, Al-Jamal KT. Anti-tumor antibody isotype response can be modified with locally administered immunoadjuvants. Drug Delivery and Translational Research. PMID 36417163 DOI: 10.1007/s13346-022-01258-8  0.657
2021 Walters AA, Dhadwar B, Al-Jamal KT. Modulating expression of inhibitory and stimulatory immune 'checkpoints' using nanoparticulate-assisted nucleic acid delivery. Ebiomedicine. 73: 103624. PMID 34688033 DOI: 10.1016/j.ebiom.2021.103624  0.549
2021 Helal DO, Rouatbi N, Han S, Tzu-Wen Wang J, Walters AA, Abdel-Mottaleb MMA, Kamel AO, Geneidi AS, Awad GAS, Al-Jamal KT. A natural protein based platform for the delivery of Temozolomide acid to glioma cells. European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V. 169: 297-308. PMID 34678408 DOI: 10.1016/j.ejpb.2021.10.007  0.732
2021 Walters AA, Santacana-Font G, Li J, Routabi N, Qin Y, Claes N, Bals S, Tzu-Wen Wang J, Al-Jamal KT. Nanoparticle-Mediated Molecular Reprogramming of Immune Checkpoint Interactions for Cancer Immunotherapy. Acs Nano. PMID 34677938 DOI: 10.1021/acsnano.1c04456  0.702
2021 Abdel-Bar HM, Walters AA, Lim Y, Rouatbi N, Qin Y, Gheidari F, Han S, Osman R, Wang JT, Al-Jamal KT. An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors. Theranostics. 11: 8738-8754. PMID 34522209 DOI: 10.7150/thno.56936  0.712
2021 Li D, Ahmed M, Khan A, Xu L, Walters AA, Ballesteros B, Al-Jamal KT. Tailoring the Architecture of Cationic Polymer Brush-Modified Carbon Nanotubes for Efficient siRNA Delivery in Cancer Immunotherapy. Acs Applied Materials & Interfaces. PMID 34170101 DOI: 10.1021/acsami.1c02627  0.731
2021 Abdel-Bar HM, Walters AA, Wang JT, Al-Jamal KT. Combinatory Delivery of Etoposide and siCD47 in a Lipid Polymer Hybrid Delays Lung Tumor Growth in an Experimental Melanoma Lung Metastatic Model. Advanced Healthcare Materials. e2001853. PMID 33661553 DOI: 10.1002/adhm.202001853  0.693
2020 Giram PS, Wang JT, Walters AA, Rade PP, Akhtar M, Han S, Faruqu FN, Abdel-Bar HM, Garnaik B, Al-Jamal KT. Green synthesis of methoxy-poly(ethylene glycol)--poly(L-lactide--glycolide) copolymer using zinc proline as a biocompatible initiator for irinotecan delivery to colon cancer . Biomaterials Science. PMID 33206082 DOI: 10.1039/d0bm01421d  0.782
2020 Xu L, Faruqu FN, Lim YM, Lim KY, Liam-Or R, Walters AA, Lavender P, Fear D, Wells CM, Tzu-Wen Wang J, Al-Jamal KT. Exosome-mediated RNAi of PAK4 prolongs survival of pancreatic cancer mouse model after loco-regional treatment. Biomaterials. 264: 120369. PMID 32977209 DOI: 10.1016/J.Biomaterials.2020.120369  0.725
2020 Walters AA, Wang JT, Al-Jamal KT. Evaluation of cell surface reactive immuno-adjuvant in combination with immunogenic cell death inducing drug for in situ chemo-immunotherapy. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 32243973 DOI: 10.1016/J.Jconrel.2020.03.029  0.681
2019 Sunoqrot S, Al-Debsi T, Al-Shalabi E, Hasan Ibrahim L, Faruqu FN, Walters A, Palgrave R, Al-Jamal KT. Bioinspired Polymerization of Quercetin to Produce a Curcumin-Loaded Nanomedicine with Potent Cytotoxicity and Cancer-Targeting Potential in Vivo. Acs Biomaterials Science & Engineering. 5: 6036-6045. PMID 33405725 DOI: 10.1021/acsbiomaterials.9b01240  0.626
2019 Faruqu FN, Wang JT, Xu L, McNickle L, Chong EM, Walters A, Gurney M, Clayton A, Smyth LA, Hider R, Sosabowski J, Al-Jamal KT. Membrane Radiolabelling of Exosomes for Comparative Biodistribution Analysis in Immunocompetent and Immunodeficient Mice - A Novel and Universal Approach. Theranostics. 9: 1666-1682. PMID 31037130 DOI: 10.7150/Thno.27891  0.763
2019 Hassan HAFM, Diebold SS, Smyth LA, Walters AA, Lombardi G, Al-Jamal KT. Application of carbon nanotubes in cancer vaccines: Achievements, challenges and chances. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 30659906 DOI: 10.1016/J.Jconrel.2019.01.017  0.556
2019 Sunoqrot S, Al-Debsi T, Al-Shalabi E, Hasan Ibrahim L, Faruqu FN, Walters A, Palgrave R, Al-Jamal KT. Bioinspired Polymerization of Quercetin to Produce a Curcumin-Loaded Nanomedicine with Potent Cytotoxicity and Cancer-Targeting Potential in Vivo Acs Biomaterials Science & Engineering. 5: 6036-6045. DOI: 10.1021/Acsbiomaterials.9B01240  0.628
2018 Mei KC, Ghazaryan A, Teoh EZ, Summers HD, Li Y, Ballesteros B, Piasecka J, Walters A, Hider RC, Mailänder V, Al-Jamal KT. Protein-Corona-by-Design in 2D: A Reliable Platform to Decode Bio-Nano Interactions for the Next-Generation Quality-by-Design Nanomedicines. Advanced Materials (Deerfield Beach, Fla.). e1802732. PMID 30144166 DOI: 10.1002/Adma.201802732  0.739
Show low-probability matches.